Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.13M | 24.34M | 23.55M | 27.53M | 31.50M |
| Total Depreciation and Amortization | 17.31M | 17.09M | 16.86M | 15.55M | 14.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 358.00K | 3.36M | 6.36M | 5.73M | 5.09M |
| Change in Net Operating Assets | -9.71M | -8.30M | -6.89M | -6.89M | -6.89M |
| Cash from Operations | 33.08M | 36.49M | 39.89M | 41.91M | 43.94M |
| Capital Expenditure | -2.75M | -4.68M | -6.61M | -7.59M | -8.57M |
| Sale of Property, Plant, and Equipment | 11.00K | 38.00K | 65.00K | 38.50K | 12.00K |
| Cash Acquisitions | -1.76M | -3.36M | -4.96M | -18.59M | -32.22M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.09M | 4.94M | 11.97M | 9.88M | 7.79M |
| Cash from Investing | -6.60M | -3.07M | 458.00K | -16.27M | -33.00M |
| Total Debt Issued | 7.55M | 6.47M | 5.38M | 4.91M | 4.44M |
| Total Debt Repaid | -14.31M | -13.12M | -11.93M | -11.79M | -11.65M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.45M | -9.98M | -10.51M | -10.51M | -10.51M |
| Other Financing Activities | 91.00K | -813.00K | -1.72M | -2.48M | -3.24M |
| Cash from Financing | -16.12M | -17.45M | -18.78M | -19.87M | -20.97M |
| Foreign Exchange rate Adjustments | -806.00K | -2.08M | -3.36M | -3.80M | -4.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.57M | 13.89M | 18.21M | 1.98M | -14.26M |